Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




May
29
Today In Oncology
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC
Local Radiotherapy May Help Control Oligometastatic Breast Cancer
TAILORx and RxPONDER Trials Shift to a Discovery Platform
Radiotherapy for Prostate Cancer: HERMES Trial Compares Two and Five Fractions
BPDCN FDA Approves Pivekimab Sunirine-pvzy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo